News

Community Engagement through Drama

Dr. Gill Black

Listen to Gill Black Podcast

Summary: Dr. Gill Black is the co-founder and Director of Health and Welfare at The Sustainable Livelihoods Foundation (SLF). In this inteview, we discuss with Dr. Black one of SLF’s groundbreaking projects that uses drama to engage local communities around issues related to TB and HIV/AIDS. The goal of the foundation is to contribute towards eliminating poverty through undertaking original research and engaging with communities to develop and advance innovative approaches to strengthening livelihoods. SLF undertakes several projects to achieve its objectives:

  • To undertake path-breaking, state of the art, pragmatic research into the constraints and obstacles to human development and make this knowledge accessible to a wider audience, through simplification and audio and visual communication
  • To undertake creative public engagement with communities, learning of their challenges and equipping them with knowledge and skills to foster resilience and strengthen their livelihood opportunities
  • To conceptualize and pioneer innovative development practice to influence policy and programs and to apply these ideas through micro-projects to demonstrate their effectiveness and sustainability

Sustainable Livelihood Foundation Gallery

More News
14 Aug 2019
FDA released the following press release on Wednesday, August 14th: The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs. “The threat of...
27 Jun 2019
-- Globe Newswire reported on June 20th -- Spero Therapeutics, Inc. , a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections and rare diseases, today...
5 Jun 2019
**Update: The US FDA Antimicrobial Drug Advisory Committee voted in favor of the NDA 14 to 4 on June 6th, 2019** The United States Food & Drug Administration (FDA) will host the Antimicrobial Drug Advisory Committee on Thursday, June 6th to discuss the new drug application (NDA) involving new...